Mohindru Mani
- SEC CIK
- 0001664708
In the past year, 2 open-market purchase filings worth $79.9K and no sales.
Current role at each company
- CRDF Cardiff Oncology, Inc.Chief Executive Officeras of Jul 16, 2026
- CTMX CytomX Therapeutics, Inc.Directoras of Jun 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $79.9K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$79.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mohindru Mani as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRDF Cardiff Oncology, Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 (view filing)4:01 PM ET | Jul 14 | 2 days | Mohindru ManiChief Executive Officer | PPurchase | +34.4K | $1.46 | +$50.0K | +139.1%59.1K after | |
| Jul 16, 2026 (view filing)4:01 PM ET | Jul 14 | 2 days | Mohindru ManiChief Executive Officer | PPurchase | +34.4K | $0.00 | $0 | –34.4K after | Derivative |
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Mohindru ManiChief Executive Officer | PPurchase | +24.7K | $1.21 | +$29.9K | New position24.7K after |